XML 183 R36.htm IDEA: XBRL DOCUMENT
v3.25.1

Equity Method Investments (Tables) | 3 Months Ended | 12 Months Ended
--- | --- | ---
Mar. 31, 2025 | Dec. 31, 2024
Equity Method Investments [Abstract] |  |
Schedule of Equity Method Investment | In the three months ended March 31, 2025, activity recorded for the Company’s equity method investment in Lab Services MSO is summarized in the following table:
Equity investment carrying amount at January 1, 2025 |  | $ | 10,636,544 |
Lab Services MSO’s net income attributable to the Company |  |  | 503,833 |
Intangible assets amortization amount |  |  | (111,156 | )
Sale of equity investment |  |  | (11,029,221 | )
Equity investment carrying amount at March 31, 2025 |  | $ | - |
| In the years ended December 31, 2024 and 2023, activity recorded for the Company’s equity method investment in Lab Services MSO is summarized in the following table:
Equity investment carrying amount at January 1, 2023 |  | $ | - |
Payment for equity method investment: |  |  |  |
The Company’s interest in the fair value of Lab Services MSO’s net assets at February 9, 2023 |  |  | 1,206,406 |
The Company’s interest in the net excess of Lab Services MSO’s fair value over net assets which was attributable to identifiable intangible assets at February 9, 2023 |  |  | 10,004,000 |
The Company’s interest in the net excess of Lab Services MSO’s fair value over net assets which was attributable to goodwill at February 9, 2023 |  |  | 9,456,261 |
Total payment for equity method investment |  |  | 20,666,667 |
Lab Services MSO’s net income attributable to the Company |  |  | 1,236,391 |
Intangible assets amortization amount |  |  | (611,356 | )
Impairment of goodwill |  |  | (9,196,682 | )
Equity investment carrying amount at December 31, 2023 |  |  | 12,095,020 |
Lab Services MSO’s net income attributable to the Company |  |  | 79,923 |
Intangible assets amortization amount |  |  | (666,932 | )
Distribution of earnings from equity investment |  |  | (611,888 | )
Impairment of goodwill |  |  | (259,579 | )
Equity investment carrying amount at December 31, 2024 |  | $ | 10,636,544 |
Schedule of Summarized Financial Information, as Provided to the Company by the Investee |  | The tables below present the summarized financial information, as provided to the Company by the investee, for the unconsolidated company:
|  | December 31, 2024 |  |  | December 31, 2023 |
Current assets |  | $ | 2,917,880 |  |  | $ | 4,930,254 |
Noncurrent assets |  |  | 4,509,185 |  |  |  | 5,228,044 |
Current liabilities |  |  | 611,391 |  |  |  | 828,713 |
Noncurrent liabilities |  |  | 4,346,725 |  |  |  | 4,104,183 |
Equity |  |  | 2,468,949 |  |  |  | 5,225,402 |
Schedule of Financial Information | The tables below present the summarized financial information, as provided to the Company by the investee, for the unconsolidated company:
|  | For the Period from January 1, 2025 through February 26, 2025 (Date of Sale) |  |  | For the Three Months Ended March 31, 2024 |
Net revenue |  | $ | 4,241,732 |  |  | $ | 3,376,372 |
Gross profit |  |  | 2,155,760 |  |  |  | 1,003,789 |
Income from operation |  |  | 1,513,000 |  |  |  | 275,026 |
Net income |  |  | 1,259,582 |  |  |  | 685,504 |
|  | For the year Ended December 31, 2024 |  |  | For the Period from February 9, 2023 (Date of Investment) through December 31, 2023 |
Net revenue |  | $ | 13,558,711 |  |  | $ | 12,699,683 |
Gross profit |  |  | 3,534,503 |  |  |  | 4,744,277 |
(Loss) income from operation |  |  | (265,754 | ) |  |  | 2,393,830 |
Net loss income |  |  | 199,808 |  |  |  | 3,090,977 |

X
- Definition Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name Regulation S-X (SX) -Number 210 -Section 12 -Subsection 04 -Paragraph a -Publisher SEC Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 942 -SubTopic 235 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3 + Details
Name: | srt_ScheduleOfCondensedBalanceSheetTableTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of condensed income statement, including, but not limited to, income statements of consolidated entities and consolidation eliminations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name Regulation S-X (SX) -Number 210 -Section 12 -Subsection 04 -Paragraph a -Publisher SEC Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 942 -SubTopic 235 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3 + Details
Name: | srt_ScheduleOfCondensedIncomeStatementTableTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3 + Details
Name: | us-gaap_EquityMethodInvestmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration